M Sutil-Vega

Sabadell, Barcelona, Spain

Articles by M Sutil-Vega

LDL-C Reduction in Diabetic Patients after Percutaneous Coronary Intervention: Is There any Difference with Non-diabetic?

N Mallofré Vila, G Torres-Ruiz, C Roca-Guerrero, et al

Published:

Citation: European Cardiology Review 2023;18:e19.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO2
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic

M Rizzo, I Colomer-Asenjo, M Sutil-Vega, et al

Citation: European Cardiology Review 2020;15:e31.

DOI:

https://doi.org/10.15420/ecr.2020.15.1.PO8
Tolerability Profile and Discontinuation Causes of Sacubitril/Valsartan Treatment in ‘Real-life’ Patients with Heart Failure and Reduced Ejection Fraction

M Rizzo, I Colomer-Asenjo, G Cabello-Molina, et al

Citation: European Cardiology Review 2020;15:e32.

DOI:

https://doi.org/10.15420/ecr.2020.15.1.PO9